Table 3.
Top 50 miRNAs associated with prostate neoplasms were predicted by GIMDA based on HMDD V2.0
| miRNA | Evidence | miRNA | Evidence |
|---|---|---|---|
| hsa‐mir‐21 | dbdemc; miR2Disease | hsa‐mir‐19a | dbdemc |
| hsa‐mir‐146a | miR2Disease | hsa‐mir‐195 | dbdemc; miR2Disease |
| hsa‐mir‐155 | Dbdemc | hsa‐mir‐200b | unconfirmed |
| hsa‐mir‐34a | dbdemc; miR2Disease | hsa‐mir‐1 | dbdemc |
| hsa‐mir‐17 | miR2Disease | hsa‐mir‐15b | dbdemc |
| hsa‐mir‐20a | miR2Disease | hsa‐mir‐101 | dbdemc; miR2Disease |
| hsa‐mir‐92a | Unconfirmed | hsa‐mir‐224 | dbdemc; miR2Disease |
| hsa‐mir‐29a | dbdemc; miR2Disease | hsa‐mir‐214 | dbdemc; miR2Disease |
| hsa‐mir‐16 | dbdemc; miR2Disease | hsa‐mir‐34c | dbdemc |
| hsa‐mir‐29b | dbdemc; miR2Disease | hsa‐mir‐335 | unconfirmed |
| hsa‐mir‐221 | dbdemc; miR2Disease | hsa‐mir‐133b | dbdemc |
| hsa‐mir‐222 | dbdemc; miR2Disease | hsa‐mir‐182 | dbdemc; miR2Disease |
| hsa‐mir‐15a | dbdemc; miR2Disease | hsa‐mir‐203 | unconfirmed |
| hsa‐mir‐126 | dbdemc; miR2Disease | hsa‐mir‐93 | unconfirmed |
| hsa‐mir‐18a | Unconfirmed | hsa‐mir‐124 | dbdemc |
| hsa‐mir‐223 | dbdemc; miR2Disease | hsa‐mir‐106a | dbdemc; miR2Disease |
| hsa‐mir‐19b | dbdemc; miR2Disease | hsa‐mir‐148a | miR2Disease |
| hsa‐mir‐31 | dbdemc; miR2Disease | hsa‐mir‐486 | unconfirmed |
| hsa‐mir‐199a | dbdemc; miR2Disease | hsa‐mir‐210 | miR2Disease |
| hsa‐mir‐133a | Dbdemc | hsa‐mir‐26a | dbdemc; miR2Disease |
| hsa‐mir‐143 | dbdemc; miR2Disease | hsa‐let‐7a | dbdemc; miR2Disease |
| hsa‐mir‐122 | Unconfirmed | hsa‐mir‐34b | dbdemc |
| hsa‐mir‐181b | dbdemc; miR2Disease | hsa‐mir‐200a | dbdemc |
| hsa‐mir‐106b | Dbdemc | hsa‐mir‐218 | dbdemc; miR2Disease |
| hsa‐mir‐146b | Unconfirmed | hsa‐mir‐127 | dbdemc; miR2Disease |
The top 1‐25 miRNAs are shown in the first column, whereas the top 26‐50 in the second. As a result, 9, 18 and 41 of top 10, top 20 and top 50 were confirmed by the databases, respectively.